These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3543432)

  • 1. [A double-blind comparative study on the efficacy of S6472, cefaclor, in the treatment of bacterial bronchitis].
    Oshima S; Yokoyama Y; Kikuiri T; Murakami T; Nishihara H; Shimizu T; Abe M; Kurihara Y; Itoh C; Takeuchi K
    Jpn J Antibiot; 1986 Oct; 39(10):2726-53. PubMed ID: 3543432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative studies of the efficacy, safety and usefulness of S6472, cefaclor and cephalexin on complicated urinary tract infection by the double-blind method].
    Kamidono S; Arakawa S; Fujii A; Kataoka N; Umezu K; Ishigami J; Hirooka K; Shimatani N; Matsushita M; Hikosaka K
    Jpn J Antibiot; 1985 Oct; 38(10):2735-69. PubMed ID: 3908727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical evaluation of S6472 (prolonged action preparation of cefaclor) in the treatment of skin and soft tissue infections. A double blind comparison of S6472 and cefaclor].
    Sakai K; Fujimoto M; Ueda T; Yura J; Shinagawa N; Ishikawa S; Tachi Y; Kobe A; Shibata Y; Doi S
    Jpn J Antibiot; 1985 Oct; 38(10):2716-34. PubMed ID: 3908726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A double blind comparative study on the efficacy of S6472, cefaclor and amoxicillin, in the treatment of bacterial pneumonia].
    Shibaki H; Chimoto T; Nakabayashi T; Ishii Y; Tosaka M; Watanabe H; Onodera S; Shimizu T; Sasaki N; Ikeda Y
    Jpn J Antibiot; 1986 Mar; 39(3):853-86. PubMed ID: 3525883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A parallel comparative double blind study of cefixime with cefaclor in the treatment of acute suppurative otitis media in children].
    Baba S; Kinoshita H; Mori Y; Suzuki K; Shimada J; Kawamura S; Onishi S; Ueda R; Kobayashi K; Itoh Y
    Jpn J Antibiot; 1987 Jan; 40(1):1-24. PubMed ID: 3295321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical studies of S6472 in otorhinolaryngologic infections].
    Baba S; Kinoshita H; Mori Y; Suzuki K; Ohyama M; Katsuta K; Furuta S; Ohno I; Noboru T; Yamamoto M
    Jpn J Antibiot; 1985 Jul; 38(7):1750-60. PubMed ID: 4068219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A double-blind comparative study of S 6472 (a long-acting cefaclor) versus a conventional cefaclor preparation in complicated urinary tract infections].
    Arakawa S; Takagi S; Matsumoto O; Kamidono S; Hirooka K; Hamami G; Matsumoto H; Saito H; Umezu K; Ishigami J
    Jpn J Antibiot; 1990 Nov; 43(11):1873-92. PubMed ID: 2287055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fundamental and clinical studies on S6472 (a new prolonged acting preparation of cefaclor) in the urological field].
    Kamidono S; Fujii A; Harada M; Arakawa S; Umezu K; Kataoka N; Ishigami J; Hirooka K; Shimatani N; Matsushita M
    Jpn J Antibiot; 1985 Mar; 38(3):869-904. PubMed ID: 3928939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical evaluation of cefpodoxime proxetil in the treatment of skin and soft tissue infections. A double blind comparison of cefpodoxime proxetil and cefaclor].
    Yura J; Shinagawa N; Mizuno A; Watanabe S; Ando M; Sakai K; Ueda T; Morimoto K; Nakamura T; Hashimoto I
    Jpn J Antibiot; 1988 Oct; 41(10):1517-37. PubMed ID: 3060626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A double-blind comparison between cefaclor and cephalexin in the treatment of dental infections].
    Horii M; Morinaga T; Takeuchi T; Shimada S; Yamanaka H; Nishimura T; Noshi Y; Okada T; Sasaki T; Takada S
    Jpn J Antibiot; 1984 Jan; 37(1):152-75. PubMed ID: 6374193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical evaluation of BMY-28100 for bacterial pneumonia in comparison with cefaclor in a double-blind study].
    Oizumi K; Watanabe A; Saito A; Tomizawa M; Nakayama I; Hiraga Y; Ohmichi M; Tamura M; Konishi K; Gomi K
    Jpn J Antibiot; 1990 Nov; 43(11):1914-47. PubMed ID: 2287058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical evaluation of sustained release preparations of cefaclor in dental infections. Comparative double blind clinical studies of sustained release preparations with a regular preparation of cefaclor].
    Horii M; Shimada S; Yamanaka H; Nishimura T; Noshi Y; Okada T; Sasaki T; Inaba O; Takada S; Kimura J
    Jpn J Antibiot; 1985 Apr; 38(4):1117-40. PubMed ID: 3897614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical evaluation of cefuroxime axetil in acute dental infections. Double blind comparative study vs. cefaclor].
    Sasaki I; Morihana T; Kaneko A; Michi K; Takahashi K; Fukuoka F; Satoh T; Yoshinari N; Ohne M; Hara H
    Jpn J Antibiot; 1990 Dec; 43(12):2035-68. PubMed ID: 2086820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Phase I clinical studies of S6472 (sustained release preparations of cefaclor)].
    Ohtomo M; Ito M; Iida M; Yasuda M; Sonoyama T; Matsuda S
    Jpn J Antibiot; 1985 Mar; 38(3):822-33. PubMed ID: 4032714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of S6472 and cefaclor on bacterial flora in adult human feces].
    Motohiro T; Aramaki M; Tanaka K; Koga T; Shimada Y; Tomita S; Sakata Y; Fujimoto T; Nishiyama T; Kuda N
    Jpn J Antibiot; 1986 Jan; 39(1):177-246. PubMed ID: 3702058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A double blind controlled study on S6472 capsules and granules in complicated urinary tract infection].
    Arakawa S; Matsui T; Tanaka K; Ishigami J; Kamidono S; Ito N; Tanaka H; Hasunuma Y; Omae H; Shinozaki M
    Jpn J Antibiot; 1994 Feb; 47(2):195-209. PubMed ID: 8151912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fundamental and clinical studies of a sustained release preparation of cefaclor in the surgical field].
    Yura J; Shinagawa N; Ishikawa S; Tachi Y; Kobe A; Shibata Y; Ito T; Tanabe M; Fukuhara A; Sakakibara O
    Jpn J Antibiot; 1985 Mar; 38(3):859-68. PubMed ID: 3897613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prolonged action preparation of cefaclor].
    Sakamoto T; Kawai S; Doi Y; Aita K; Sonoyama T; Nishimura K; Matsuda S; Ito M; Imagawa T; Yasuda M
    Jpn J Antibiot; 1985 Mar; 38(3):813-21. PubMed ID: 3897611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical results of cefaclor treatment of infections of oral regions].
    Yoshida Y; Kita T; Kanematsu N; Sato K; Kawata K; Fukuta N; Sato J
    Jpn J Antibiot; 1984 Mar; 37(3):318-28. PubMed ID: 6737694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical evaluation of S 6472 granule preparation (sustained-release cefaclor) in chronic bronchitis].
    Tanimoto H; Nakamori Y
    Jpn J Antibiot; 1988 Sep; 41(9):1319-24. PubMed ID: 3241331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.